10-68468207-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001080449.3(DNA2):c.357G>A(p.Leu119Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.101 in 1,610,440 control chromosomes in the GnomAD database, including 10,558 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.092 ( 945 hom., cov: 32)
Exomes 𝑓: 0.10 ( 9613 hom. )
Consequence
DNA2
NM_001080449.3 synonymous
NM_001080449.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.36
Genes affected
DNA2 (HGNC:2939): (DNA replication helicase/nuclease 2) This gene encodes a member of the DNA2/NAM7 helicase family. The encoded protein is a conserved helicase/nuclease involved in the maintenance of mitochondrial and nuclear DNA stability. Mutations in this gene are associated with autosomal dominant progressive external ophthalmoplegia-6 (PEOA6) and Seckel syndrome 8. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-68468207-C-T is Benign according to our data. Variant chr10-68468207-C-T is described in ClinVar as [Benign]. Clinvar id is 257345.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-68468207-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-4.36 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.235 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNA2 | NM_001080449.3 | c.357G>A | p.Leu119Leu | synonymous_variant | 3/21 | ENST00000358410.8 | NP_001073918.2 | |
DNA2 | XM_006717680.3 | c.447G>A | p.Leu149Leu | synonymous_variant | 4/22 | XP_006717743.1 | ||
DNA2 | XM_017015799.1 | c.-170G>A | 5_prime_UTR_variant | 1/18 | XP_016871288.1 | |||
DNA2 | NR_102264.2 | n.446G>A | non_coding_transcript_exon_variant | 4/22 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0922 AC: 14014AN: 152022Hom.: 940 Cov.: 32
GnomAD3 genomes
AF:
AC:
14014
AN:
152022
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.136 AC: 33500AN: 246824Hom.: 3117 AF XY: 0.136 AC XY: 18258AN XY: 133920
GnomAD3 exomes
AF:
AC:
33500
AN:
246824
Hom.:
AF XY:
AC XY:
18258
AN XY:
133920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.102 AC: 148304AN: 1458300Hom.: 9613 Cov.: 31 AF XY: 0.106 AC XY: 76692AN XY: 725208
GnomAD4 exome
AF:
AC:
148304
AN:
1458300
Hom.:
Cov.:
31
AF XY:
AC XY:
76692
AN XY:
725208
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0923 AC: 14039AN: 152140Hom.: 945 Cov.: 32 AF XY: 0.0975 AC XY: 7247AN XY: 74356
GnomAD4 genome
AF:
AC:
14039
AN:
152140
Hom.:
Cov.:
32
AF XY:
AC XY:
7247
AN XY:
74356
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
634
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 23, 2016 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 02, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at